Showing results (141-150 of 298) with videos related to

Sort By:
Pageof 30
Nature Communications|December 3, 2024
Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infectionsJoshua Osowicki, Hannah R Frost, Kristy I Azzopardi, et al.
Science Advances|February 18, 2020
Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccinesMariusz Skwarczynski, Guangzu Zhao, Jennifer C Boer, et al.
Vaccine|May 19, 2019
Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection studyJoshua Osowicki, Kristy I Azzopardi, Ciara Baker, et al.
Trends in Parasitology|August 6, 2022
A vaccine for human babesiosis: prospects and feasibilityHanan Al-Nazal, Leanne M Low, Sanjai Kumar, et al.
Polymers|August 28, 2021
Development of <i>In-Situ</i> Spray for Local Delivery of Antibacterial Drug for Hidradenitis Suppurativa: Investigation of Alternative FormulationYoke Lan Wong, Manisha Pandey, Hira Choudhury, et al.
Carbohydrate Polymers|June 8, 2014
Synthesis of a novel acrylated abietic acid-g-bacterial cellulose hydrogel by gamma irradiationMuhammad Mustafa Abeer, Mohd Cairul Iqbal Mohd Amin, Azwan Mat Lazim, et al.
Recent Patents on Nanotechnology|October 18, 2023
Nano-approaches and Recent Advancements in Strategies to Combat Challenges Associated with Thyroid Cancer TherapiesGurmehar Singh, Jatin Rathee, Triveni, et al.
Bioconjugate Chemistry|April 10, 2014
Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccinesPeter M Moyle, Wei Dai, Yingkai Zhang, et al.
The Indian Journal of Medical Research|July 3, 2004
Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide constructColleen Olive, Michael Batzloff, Aniko Horváth, et al.
Infection and Immunity|April 22, 2003
Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogensColleen Olive, Michael Batzloff, Aniko Horváth, et al.
Pageof 30